CN105520054A - Formula of fine dried noodles for treating diabetes and preparation process - Google Patents
Formula of fine dried noodles for treating diabetes and preparation process Download PDFInfo
- Publication number
- CN105520054A CN105520054A CN201610051132.6A CN201610051132A CN105520054A CN 105520054 A CN105520054 A CN 105520054A CN 201610051132 A CN201610051132 A CN 201610051132A CN 105520054 A CN105520054 A CN 105520054A
- Authority
- CN
- China
- Prior art keywords
- parts
- flour
- diabetes
- wheat
- fineness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 89
- 235000012149 noodles Nutrition 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 238000011282 treatment Methods 0.000 claims abstract description 57
- 235000013312 flour Nutrition 0.000 claims abstract description 46
- 235000013305 food Nutrition 0.000 claims abstract description 36
- 241000209140 Triticum Species 0.000 claims abstract description 16
- 235000021307 Triticum Nutrition 0.000 claims abstract description 16
- 235000015099 wheat brans Nutrition 0.000 claims abstract description 15
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 14
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 14
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 14
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 14
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 14
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 14
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 14
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 14
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 14
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 14
- 244000268590 Euryale ferox Species 0.000 claims abstract description 14
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 14
- 241000287828 Gallus gallus Species 0.000 claims abstract description 14
- 108010068370 Glutens Proteins 0.000 claims abstract description 14
- 240000005979 Hordeum vulgare Species 0.000 claims abstract description 14
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 14
- 229920002752 Konjac Polymers 0.000 claims abstract description 14
- 241000234435 Lilium Species 0.000 claims abstract description 14
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 14
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 14
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 14
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 14
- 235000021312 gluten Nutrition 0.000 claims abstract description 14
- 239000012528 membrane Substances 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 11
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract 5
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 5
- 239000000047 product Substances 0.000 claims description 22
- 235000007354 Coix lacryma jobi Nutrition 0.000 claims description 12
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 12
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 12
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 12
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 12
- 244000194101 Ginkgo biloba Species 0.000 claims description 12
- 210000004317 gizzard Anatomy 0.000 claims description 12
- 238000005516 engineering process Methods 0.000 claims description 11
- 238000012545 processing Methods 0.000 claims description 10
- 238000010298 pulverizing process Methods 0.000 claims description 10
- 238000009472 formulation Methods 0.000 claims description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 7
- 229940072033 potash Drugs 0.000 claims description 7
- 235000015320 potassium carbonate Nutrition 0.000 claims description 7
- 230000032683 aging Effects 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000011265 semifinished product Substances 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 abstract description 56
- 239000008280 blood Substances 0.000 abstract description 55
- 235000000346 sugar Nutrition 0.000 abstract description 35
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 15
- 235000011201 Ginkgo Nutrition 0.000 abstract 2
- 235000008100 Ginkgo biloba Nutrition 0.000 abstract 2
- 241000592346 Ginkgophyta Species 0.000 abstract 2
- 235000004879 dioscorea Nutrition 0.000 abstract 2
- 229910000027 potassium carbonate Inorganic materials 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 35
- 239000008103 glucose Substances 0.000 description 26
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 26
- 235000012054 meals Nutrition 0.000 description 24
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 18
- 235000005911 diet Nutrition 0.000 description 18
- 230000006870 function Effects 0.000 description 14
- 102000004877 Insulin Human genes 0.000 description 13
- 108090001061 Insulin Proteins 0.000 description 13
- 229940125396 insulin Drugs 0.000 description 13
- 235000016709 nutrition Nutrition 0.000 description 12
- 230000000378 dietary effect Effects 0.000 description 11
- 230000035764 nutrition Effects 0.000 description 11
- 241000209205 Coix Species 0.000 description 9
- 241001092040 Crataegus Species 0.000 description 9
- 235000007882 dietary composition Nutrition 0.000 description 9
- 235000001727 glucose Nutrition 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 230000000291 postprandial effect Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 230000037213 diet Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 150000002304 glucoses Chemical class 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 230000036186 satiety Effects 0.000 description 3
- 235000019627 satiety Nutrition 0.000 description 3
- 244000283207 Indigofera tinctoria Species 0.000 description 2
- 102100023915 Insulin Human genes 0.000 description 2
- 229940127003 anti-diabetic drug Drugs 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 235000020880 diabetic diet Nutrition 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 235000013384 milk substitute Nutrition 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- -1 peak value is low Substances 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a formula of fine dried noodles for treating diabetes. The formula of the fine dried noodles comprises, in parts by weight, 20-30 parts of highland barley flour, 40-50 parts of wheat flour, 20-40 parts of wheat gluten flour, 30-40 parts of konjaku flour, 10-20 parts of ginkgoes, 10-20 parts of hawthorn fruits, 5-8 parts of chicken's gizzard-membrane, 20-30 parts of lotus seeds, 4-8 parts of gordon euryale seeds, 40-50 parts of Chinese yams, 60-70 parts of coix seeds, 30-40 parts of lilies, 20-30 parts of wheat bran and 10-20 parts of potassium carbonate. A preparation method of the fine dried noodles comprises steps as follows: (1), the konjaku flour, the ginkgoes, the hawthorn fruits, the chicken's gizzard-membrane, the lotus seeds, the gordon euryale seeds, the Chinese yams, the coix seeds and the lilies are mixed, ground according to the formula and processed by a high-speed micro powder machine, and the fineness of the powder is 200-220 meshes; (2), the wheat bran is processed by the high-speed micro powder machine, and the fineness of the wheat bran is 200-220 meshes; (3), the highland barley flour, the wheat flour and the wheat gluten flour are ground and processed, and the fineness of the ground powder is 80-100 meshes; (4), the raw materials are mixed sufficiently by a powder food premixing device, special treatment medicated food composition replaces original staple food of a patient suffering from diabetes, the blood sugar of the patient suffering from diabetes cannot rise after the patient takes the fine dried noodles, and a certain hypoglycemic effect can be realized.
Description
Technical field
The present invention relates to nutritional need technical field of food preparation, be specifically related to a kind of dried noodles formulation and preparation technology of adjuvant therapy of diabetes.
Background technology
Up-to-date 2009 editions treatment of diabetes standards of american diabetes association's issue that the whole world is the most authoritative are pointed out: normalized medical nutrient treatment (MedicalNutritonTherapy, MNT) is the basis of diabetes mellitus prevention and treatment.By taking in reasonable diet targetedly; be unlikely to a large amount of insulin of needs or hypoglycemic medicine and reduce the abnormal blood sugar raised because of feed; glycometabolism system burden can be alleviated; B cell is had a rest; just can promote that blood sugar drops on an empty stomach normal or close normal; impel glucose in urine to disappear, correct metabolic disorder, prevent various complication.
Before the method for not curing diabetes, the postprandial blood sugar controlling each meal is up to standard, and then could reach whole day 24 hours blood glucose up to standard, this is the ideal treatment target that doctor and patient is expected.After insulin invention, although diabetes medical technology there has been a lot of new progress, but it is the problem that we cannot avoid that the blood glucose fluctuation rate of patient does not significantly promote, and diabetes mellitus in China " five drive carriage " advocate professor Xiang Hongding points out: blood sugar is not up to standard, equals not treat.The pathogenesis of diabetes and essence thereof, determine treatment and can not rely on merely insulin and medicine, the Primary Care status of dietary therapy and important function can not be ignored!
Always extremely emphasize the importance of diet management in diabetes in theory, but the diabetic diet therapy that a kind of easy implementation has hypoglycemic effect and food and drink form thereof can not be established in practice so far, let alone its compliance and standardization.Current many diabetics think to keep on a diet and are difficult to accomplish, thus have to select simple or depend on antidiabetic drug or insulinize unduly! Countless clinical experience proves, to be that dietetic treatment is improper maybe can not adhere to the great majority that prove an abortion for the treatment of diabetes; And the key of failure is that existing diet management in diabetes cannot be carried out effectively.
Glucose resultant index, be called for short glycemic index, the physiologic parameters that the basis of tangible dietary fiber and insulin resistance theory is set up, be can certain things of precise reaction or certain meals composition on blood sugar concentration impact an efficiency index, it is the important parameter instructing diabetic diet, after the food that GI is high or meals composition enter stomach, digestion is fast, absorb fast, glucose enters blood rapidly, blood sugar concentration fluctuation is large, otherwise, the food that GI is low or meals long at gastrointestinal residence time, absorb slow, after glucose enters blood, peak value is low, blood sugar concentration fluctuation is little.
Current nutrition treatment mainly with the absorption of total amount of heat of keeping on a diet for target, although there is numerous scientific guidances to follow, but operability is not strong in real life, too much " outmoded restrictions " make diabetes patient at a loss as to what to do, compliance is poor, quality of life declines, and the effect of nutrition treatment is also just difficult to really embody.Diabetes seize the life of nearly 4,000,000 people every year.IDF (IDF) estimates, by 2025, the whole world had nearly 3.8 hundred million people will suffer from diabetes, is difficult to imagine, so huge colony is all faced with the problem of " difficulty of having a meal " every day.The key of overcoming difficulties is that exploitation is effective, practical, compliance standardization medical nutrient treatment new method that is good, food and drink carrys out combination medicine, reaches the ideal treatment target improving fasting blood-glucose, postprandial blood sugar, whole day 24 hours blood glucose compliance rate.
Summary of the invention
In order to solve the above problems, the invention provides a kind of dried noodles formulation and the preparation technology that treat diabetes, the original staple food of alternative diabetes patient is taken with special treatment dietary composition, do not limit staple food amount, non-staple foodstuff is normally eaten, satiety is strong, diabetes patient not only can be eaten, and can also have enough, allow the rising that not only can not cause postprandial blood sugar after diabetes patient, certain blood sugar reducing function can also be played, Be very effective, reach the object of nutrition treatment, effectively can solve the problem in background technology.
To achieve these goals, the technical solution used in the present invention is as follows: a kind of dried noodles formulation for the treatment of diabetes, is characterized in that, is made up of following weight fraction:
Highland barley flour 20-30 part, wheat flour 40-50 part, Gluten 20-40 part, konjaku flour 30-40 part, gingko 10-20 part, hawthorn 10-20 part, the membrane of a chicken's gizzard 5-8 part, lotus seeds 20-30 part, Gorgon fruit 4-8 part, Chinese yam 40-50 part, seed of Job's tears 60-70 part, lily 30-40 part, wheat bran 20-30 part, potash 10-20 part.
Further, be made up of following weight fraction:
Highland barley flour 20 parts, wheat flour 40 parts, Gluten 20 parts, konjaku flour 30 parts, gingko 10 parts, hawthorn 10 parts, the membrane of a chicken's gizzard 5 parts, 20 parts, lotus seeds, Gorgon fruit 4 parts, Chinese yam 40 parts, the seed of Job's tears 60 parts, lily 30 parts, 20 parts, wheat bran, 10 parts, potash.
The present invention have also been devised a kind of preparation technology treating the vermicelli of diabetes in addition, comprises the steps:
(1) konjaku flour, gingko, hawthorn, the membrane of a chicken's gizzard, lotus seeds, Gorgon fruit, Chinese yam, the seed of Job's tears, lily are pressed formula co-grinding, through the processing of high speed pulverizing mill, fineness is 200-220 order;
(2) processed through high speed pulverizing mill by wheat bran, fineness is 200-220 order again;
(3) then highland barley flour, wheat flour and Gluten are pulverized processing, fineness is 80-100 order;
(4) above-mentioned raw materials is fully adjusted powder through powdered food product premixing mixing apparatus;
(5) by the semi-finished product obtained in step (4), liquid is made for subsequent use;
(6) major ingredient is mixed, be equipped with the auxiliary material got ready and become dough;
(7) dough is put into aging machine slaking;
(8) finally finished product vermicelli are made through compressing tablet, slitting and drying again.
Beneficial effect of the present invention is: the present invention takes the original staple food of alternative diabetes patient with special treatment dietary composition, do not limit staple food amount, non-staple foodstuff is normally eaten, satiety is strong, diabetes patient not only can be eaten, and can also have enough, allow the rising that not only can not cause postprandial blood sugar after diabetes patient, certain blood sugar reducing function can also be played, Be very effective, reach the object of nutrition treatment; There is the dietary function significantly promoting fasting blood-glucose, after the meal 2 hours blood glucoses, whole day 24 hours blood glucose up to standard, can well control to depend merely on insulin and the most difficult postprandial blood sugar morning controlled well of hypoglycemic medicine, and cooperatively interact through medicine and special treatment meals, comprehensive function, really achieve the nutrition treatment target maintaining desirable blood sugar level.
Accompanying drawing illustrates:
Fig. 1 is present invention process flow chart.
Detailed description of the invention
With reference to the accompanying drawings and following embodiment, can better understand the present invention.But those skilled in the art will readily understand, the content described by embodiment only for illustration of the present invention, and should can not limit the present invention described in detail in claims yet.
Embodiment 1:
Treat a dried noodles formulation for diabetes, it is characterized in that, be made up of following weight fraction:
Highland barley flour 20 parts, wheat flour 40 parts, Gluten 20 parts, konjaku flour 30 parts, gingko 10 parts, hawthorn 10 parts, the membrane of a chicken's gizzard 5 parts, 20 parts, lotus seeds, Gorgon fruit 4 parts, Chinese yam 40 parts, the seed of Job's tears 60 parts, lily 30 parts, 20 parts, wheat bran, 10 parts, potash.
Its preparation technology, comprises the steps:
(1) konjaku flour, gingko, hawthorn, the membrane of a chicken's gizzard, lotus seeds, Gorgon fruit, Chinese yam, the seed of Job's tears, lily are pressed formula co-grinding, through the processing of high speed pulverizing mill, fineness is 200-220 order;
(2) processed through high speed pulverizing mill by wheat bran, fineness is 200-220 order again;
(3) then highland barley flour, wheat flour and Gluten are pulverized processing, fineness is 80-100 order;
(4) above-mentioned raw materials is fully adjusted powder through powdered food product premixing mixing apparatus.
(5) by the semi-finished product obtained in step (4), liquid is made for subsequent use;
(6) major ingredient is mixed, be equipped with the auxiliary material got ready and become dough;
(7) dough is put into aging machine slaking;
(8) finally finished product vermicelli are made through compressing tablet, slitting and drying again.
Embodiment 2:
Treat a dried noodles formulation for diabetes, it is characterized in that, be made up of following weight fraction:
Highland barley flour 25 parts, wheat flour 45 parts, Gluten 30 parts, konjaku flour 35 parts, gingko 15 parts, hawthorn 15 parts, the membrane of a chicken's gizzard 7 parts, 25 parts, lotus seeds, Gorgon fruit 6 parts, Chinese yam 45 parts, the seed of Job's tears 65 parts, lily 35 parts, 25 parts, wheat bran, 15 parts, potash.
Its preparation technology, comprises the steps:
(1) konjaku flour, gingko, hawthorn, the membrane of a chicken's gizzard, lotus seeds, Gorgon fruit, Chinese yam, the seed of Job's tears, lily are pressed formula co-grinding, through the processing of high speed pulverizing mill, fineness is 200-220 order;
(2) processed through high speed pulverizing mill by wheat bran, fineness is 200-220 order again;
(3) then highland barley flour, wheat flour and Gluten are pulverized processing, fineness is 80-100 order;
(4) above-mentioned raw materials is fully adjusted powder through powdered food product premixing mixing apparatus.
(5) by the semi-finished product obtained in step (4), liquid is made for subsequent use;
(6) major ingredient is mixed, be equipped with the auxiliary material got ready and become dough;
(7) dough is put into aging machine slaking;
(8) finally finished product vermicelli are made through compressing tablet, slitting and drying again.
Embodiment 3:
Treat a dried noodles formulation for diabetes, it is characterized in that, be made up of following weight fraction:
Highland barley flour 30 parts, wheat flour 50 parts, Gluten 40 parts, konjaku flour 40 parts, gingko 20 parts, hawthorn 20 parts, the membrane of a chicken's gizzard 8 parts, 30 parts, lotus seeds, Gorgon fruit 8 parts, Chinese yam 50 parts, the seed of Job's tears 70 parts, lily 40 parts, 30 parts, wheat bran, 20 parts, potash.
Its preparation technology, comprises the steps:
(1) konjaku flour, gingko, hawthorn, the membrane of a chicken's gizzard, lotus seeds, Gorgon fruit, Chinese yam, the seed of Job's tears, lily are pressed formula co-grinding, through the processing of high speed pulverizing mill, fineness is 200-220 order;
(2) processed through high speed pulverizing mill by wheat bran, fineness is 200-220 order again;
(3) then highland barley flour, wheat flour and Gluten are pulverized processing, fineness is 80-100 order;
(4) above-mentioned raw materials is fully adjusted powder through powdered food product premixing mixing apparatus.
(5) by the semi-finished product obtained in step (4), liquid is made for subsequent use;
(6) major ingredient is mixed, be equipped with the auxiliary material got ready and become dough;
(7) dough is put into aging machine slaking;
(8) finally finished product vermicelli are made through compressing tablet, slitting and drying again.
The present invention treats the routine clinical trial of diabetes B 40:
(1) research object: randomly draw clinical diagnosis in BJ Union Hospital clear and definite, and after long-term regular treatment fasting blood-glucose or 2 hours blood glucoses or glycosylated hemoglobin are not up to standard after the meal diabetes B 40 example, wherein meet the male sex 15 into set condition, average weight 72.79kg, women 25, average weight 61.93kg, 63.7 years old mean age, constitutional index 25.88, body fat percentage 0.71, diabetes average course of disease 11.97, on average 2 hours blood glucose 10.46mol/L after the meal.
(2) inclusion criteria: 1, confirmation is also actively meeting subject diabetes B patient; 2, fasting blood-glucose 6.2mol/L; 3, hypoglycemic medicine kind or dosage is used to remain unchanged more than 2 months; 4, adhere to that edible high microsteping staple food or multielement soya-bean milk substitute staple food in strict accordance with doctor's advice regulation.
(3) test method: detect fasting blood-glucose and 2 hours blood glucoses after the meal to BJ Union Hospital Nutriology Dept. during 1,3,5 7-8 in morning weekly, arrive dining room again and get high microsteping staple food or multielement soya-bean milk, the kind of the hypoglycemic medicine quoted of all cases and insulin and metering thereof and exercise treatment regimen identical; Then observe 4 weeks.
(4) observation index: 1, sign Index: blood pressure, heart rate, body weight, body fat, waistline and hip circumference; 2, quality of life: hunger, compliance, defaecation, times of defecation, enuresis nocturna number of times; 3, laboratory indexes: routine blood test, routine urinalysis, liver function, renal function, blood fat, blood sugar, carbohydrate chemistry clearance permit table, FPI; 4, drug dose: orally-taken blood sugar reducing medicine, insulin; 5, blood glucose fluctuation rate: fasting blood-glucose, after the meal 2 hours blood glucose compliance rates.(5) statistical method: all data input application spss11.5 plate softwares before and after the test of this group case carry out statistical disposition, and adopt t inspection to carry out correlation analysis, p < 0.05 has statistical significance.
(6) result: after experiment terminates, have 38 routine patients and complete experiment, 2 examples (men and women is a case each) lost to follow-up, reason lost to follow-up is not for adhering to that Wednesday time gets staple food and soya-bean milk to hospital, test pilot process carries out finger blood blood sugar monitoring to patient, patient's readme postprandial blood sugar of 80% obviously declines than before, spirit and muscle power do not have significant change, sleep improvement, 14 patients carry out subtracting medicine according to own situation in experimentation, in case hemostasis sugar occurs, 24 patients adhere to scheme, before and after patient, body function does not have significant change, , TC, LDL is improved, five statistical significances, experimental result is as following table.
Table 1
Project | Before | After | T | P |
Body weight | 66.22±12.27 | 64.45±12.32 | 6.596 | <0.001 |
Waistline | 89.52±9.73 | 86.08±7.59 | 5.039 | <0.001 |
Hip circumference | 97.62±7.69 | 97.68±7.59 | -0.121 | =0.905 |
Body lipid amount | 21.68±9.53 | 20.01±6.21 | 1.676 | =0.102 |
Body fat % | 0.31±0.72 | 0.31±0.57 | 0.665 | =0.510 |
Table 2
Project | Before | After | T | P |
Hbalc | 0.068±0.01 | 0.066±0.01 | 3.499 | <0.001 |
TC | 4.51±0.82 | 4.56±0.82 | -1.446 | =0.158 |
TG | 1.34±0.80 | 1.26±0.80 | 2.325 | <0.05 |
HDL | 1.30±0.33 | 1.45±0.33 | -0.098 | =0.922 |
LDL | 2.75±0.77 | 2.98±0.77 | -1.461 | =0.110 |
INS | 3.26±3.91 | 4.55±3.91 | -2.413 | <0.05 |
2hpG | 10.46±2.48 | 7.37±2.48 | 7.243 | <0.001 4 --> |
FPG | 6.29±1.98 | 6.84±1.98 | -1.005 | =0.322 |
In order to verify the effect of this alimentotheray for stabilizing blood sugar, BJ Union Hospital's Nutriology Dept. has carried out the clinical testing of scientific and precise to it, final result shows: high dietary-fiber (HDF) hypoglycemia patient (LGI) meals form, and has significant to reduce diabetes 1h-2h-3h blood sugar and eliminate the effect of hunger after the meal in real time.Compare before and after 40 routine T2DM patients 4 weeks, HbAIc significantly declines (P < 0.01), 2hPG significantly declines (P < 0.01), 2hPG compliance rate (≤8.0mmol/L) brings up to test rear 61% by testing front 16%, TG obviously declines (P < 0.05), INS obviously rises (P < 0.05), body weight significantly alleviates (P < 0.01), the remarkable shrinking of waistline (P < 0.01), non-evident effect.More clinical verification situation can refer to " exploration of diabetes nutrition treatment new method " (diabetes mellitus in China magazine the 17th volume the 3rd phase ChinJDiabetes in 2009, March2009, Vol17, No3, P244-245); " anti-sugared meals GI and application prospect pre-test thereof " (Chinese practical medical science volume the 6th phase ChinaPracMed February the 4th in 2009, Feb2009, Vol.4, No.6, P213).
Autumn raw hall diabetes special treatment dietary composition, safe and effectively has no side effect, not containing any hypoglycemic effect Western medicine.
September 19 in 2008, central laboratory of Nikkei Beijing Disease Prevention and Control Centre was strictly detected, and did not detect autumn raw hall diabetes nutrition treatment meals containing hypoglycemic medicine composition.
January 12 in 2009, Nikkei TaiWan, China ILAC Ai Mo biological medicine carried out cytotoxicity experiment detection, proved this product nontoxicity and had the effect strengthening cellular immunity function.
At present, this alimentotheray has been applied in the diet of division of endocrinology inpatient by BJ Union Hospital's Nutriology Dept., achieves desirable result for the treatment of.By facts have proved, these means of application diabetes nutrition alternative medicine, numerous diabetics can be helped better to control blood sugar, improve the health status of diabetic comprehensively, be a kind of effective and feasible and Novel diabetes alimentotheray being left to be desired and promoting.
Autumn raw hall diabetes special treatment dietary composition, reaching in the R&D process of 26 years, in the whole nation, tens hospitals have carried out clinical observation, and clinical effectiveness obtains sufficient affirmative, after launch, starts to be applied to clinical treatment at national various big hospital.
The market advantage of the present invention:
1, audient crowd is extensive, and the market demand constantly increases:
The treatment of diabetes is global difficult problems, and the whole world all generally acknowledges that it is the disease that can not be cured, and diabetes patient is once ill need are taken medicine all the life, and dietary therapy, also will be lifelong with it as the important component part of diabetes complex treatment.Thus it also brings a huge market.Only 2007, the expense that the whole world is used for treating diabetes and prevention was approximately 2,320 hundred million dollars, expects 2025, and this numeral will reach 3,000 hundred million dollars, and number of patients will more than 3.8 hundred million.Along with change and the urbanization process quickening of expanding economy, people life style, diabetes population will increase more rapid.
The indigo plant sea in 2, market orientation accurately, treating diabetes field:
Treating diabetes product is a huge market at all times, and in this market, medicine, health products are countless, but present global treatment level is: through drug therapy blood glucose fluctuation rate less than 30%, is it why low so?
" diabetes integrated control guide " is pointed out: countless clinical experience shows, to be exactly that dietetic treatment is improper maybe can not adhere to the most important reason for the treatment of diabetes failure.The dietary therapy past is, is now, be, be forever the foundation stone of diabetes complex treatment in the future, no matter 1 type, diabetes B or impaired glucose tolerance person, no matter state of an illness weight, no matter whether use hypoglycemic medicine, dietary therapy is the most most basic remedy measures of diabetes all the time, must adhere to for a long time, strict implement.Visible, because market does not have can the staple food products of real partner treatment, thus have impact on the effect for the treatment of diabetes.We study the special meals staple food products of diabetes series of release, and it avoids medicine various in style, field of health care products, and thus it is the indigo plant sea for the treatment of diabetes product scope.
3, solve diabetes patient to have a meal a difficult problem, meet the special market demand:
We are by segment the market demand of diabetic person consumes, by product commercially differentiation orientate " solution diabetes patient have a meal difficult problem " as
So huge diabetic population, are they now in the urgent need to assorted petty? after have passed through various drug treatment, blood glucose fluctuation rate is still less than 30%, reason is " pathogenesis of diabetes and essence thereof; determine treatment and can not rely on insulin and medicine merely or excessively, the Primary Care status of dietary therapy and important function can not be ignored." as seen they it is desirable that a kind of can the diet of real partner treatment, a kind ofly them can be allowed to have enough and can not the staple food of raise blood sugar.The specific demand in this market visible solves food problem exactly, solves food problem and also just solves control blood sugar problem, solve quality of life problem.
China doctors'associations NI director BJ Union Hospital dietitian Malaysia side represents, in existing diabetes relevant healthcare and food product, autumn raw hall diabetes special treatment dietary composition is the product that uniquely may be used for clinical treatment.
Be different from the product of existing diabetes relevant healthcare product and food service industry, autumn raw hall diabetes special treatment dietary composition is that a unique diabetes patient that can walk put on the dining table as staple food treats meals.With the staple food of this products substitution diabetes patient, limitation can be removed, need not calculate, have enough as degree, the mode dietetic life simply and easily that allowed patient again revert to of enriched nutritive supplement; This therapy makes diabetes patient's quality of life significantly improve, and is convenient to dailyly to adhere to, finally breaks away from the misery of taking medicine all the life.
4, significant result for the treatment of, the core competitiveness of highlight products:
Autumn raw hall biotechnology (Beijing) Co., Ltd associating Chinese Academy of Medical Sciences Beijing Union Medical College Hospital Nutriology Dept., exploitation diabetes standardization medical nutrient treatment new method, combination medicine, superposition curative effect, blood glucose fluctuation rate increases substantially, and treatment compliance rate increases substantially.
In whole diabetes complex treatment process, blood sugar is reduced by adopting autumn raw hall diabetes special treatment meals to regulate, can replace or partly replace the blood sugar reducing function of insulin and hypoglycemic medicine, the pathology pancreas that can't bear the heavy load is recuperated recovery, thus can stop and even reversing insulin and antidiabetic drug is used more and more, the state of an illness is more and more serious vicious circle.Adhering to taking month most patients all can blood glucose fluctuation; Take the consumption that three months some patients can reduce insulin and hypoglycemic medicine; Long-term taking, a few patients even can be stopped using insulin and hypoglycemic medicine, departs from the predicament of taking medicine all the life.
BJ Union Hospital's clinical testing shows:
Autumn raw hall diabetes special treatment dietary composition has the dietary function significantly promoting fasting blood-glucose, after the meal 2 hours blood glucoses, whole day 24 hours blood glucose up to standard, can well control to depend merely on insulin and the most difficult postprandial blood sugar morning controlled well of hypoglycemic medicine, and cooperatively interact through medicine and special treatment meals, comprehensive function, really achieve the nutrition treatment target maintaining desirable blood sugar level.Blood glucose fluctuation rate by test front 16% bring up to test after 61%!
5, a great variety of product lines, and carrier is convenient to secondary development:
In order to meet the different eating habit of diabetes patient, autumn raw hall diabetes special treatment dietary composition contains flours, the multiple products such as five cereals, except existing product, composite flour also can make various style wheaten food, simple and convenient, to meet people eating habit.Also can be developed into and downstream product that powder is raw material simultaneously, such as: cake, biscuit, the high value added product such as quick-frozen food, instant food.
6, the mode complying with the trend Non-medicine intervention in epoch solve treating diabetes problem be take advantage of a situation be:
Good product, except needing to possess all advantages of self, also will be taken advantage of a situation, namely consistent with large environment and trend, consistent with the strategy of national government regular period and strategy.The situation that current China Disease epizootic faces is, the chronic patient of 20% has consumed the medical expense of 80%, cause country for medical treatment expenditure can't bear the heavy load, and really need the difficult severe of spending, the payment rate of medical insurance is very low again, causes difficulty for guarantee people ' s health.So the Ministry of Public Health, Department of Social Security dispatch a joint document, require to set up a kind of pattern as early as possible, solve the medical care problem of vast chronic patient by the mode of Non-medicine intervention.In diabetes patient Shi Manbing colony, topmost main one-tenth part, once ill, takes medicine all the life.Our product is by substituting the medical nutrient treatment mode of diabetes patient's staple food, control the blood sugar of diabetes patient, improve the compliance rate of blood sugar, diabetes patient the is broken away from misery of taking medicine all the life, alleviates the medical burden of country, achieves the medical care problem solving chronic patient by the mode of Non-medicine intervention, this is the act taken advantage of a situation, benefit the nation and the people, be bound to obtain national support energetically, bring glad tidings to numerous diabetes patients.
The present invention takes the original staple food of alternative diabetes patient with special treatment dietary composition, do not limit staple food amount, non-staple foodstuff is normally eaten, satiety is strong, diabetes patient not only can be eaten, and can also have enough, allow the rising that not only can not cause postprandial blood sugar after diabetes patient, certain blood sugar reducing function can also be played, Be very effective, reach the object of nutrition treatment; There is the dietary function significantly promoting fasting blood-glucose, after the meal 2 hours blood glucoses, whole day 24 hours blood glucose up to standard, can well control to depend merely on insulin and the most difficult postprandial blood sugar morning controlled well of hypoglycemic medicine, and cooperatively interact through medicine and special treatment meals, comprehensive function, really achieve the nutrition treatment target maintaining desirable blood sugar level.
Specific embodiment described herein is only to the explanation for example of the present invention's spirit.Those skilled in the art can make various amendment or supplement or adopt similar mode to substitute to described specific embodiment, but can't depart from spirit of the present invention or surmount the scope that appended claims defines.
Claims (3)
1. treat a dried noodles formulation for diabetes, it is characterized in that, be made up of following weight fraction:
Highland barley flour 20-30 part, wheat flour 40-50 part, Gluten 20-40 part, konjaku flour 30-40 part, gingko 10-20 part, hawthorn 10-20 part, the membrane of a chicken's gizzard 5-8 part, lotus seeds 20-30 part, Gorgon fruit 4-8 part, Chinese yam 40-50 part, seed of Job's tears 60-70 part, lily 30-40 part, wheat bran 20-30 part, potash 10-20 part.
2. a kind of dried noodles formulation for the treatment of diabetes according to claim 1, is characterized in that, be made up of following weight fraction:
Highland barley flour 20 parts, wheat flour 40 parts, Gluten 20 parts, konjaku flour 30 parts, gingko 10 parts, hawthorn 10 parts, the membrane of a chicken's gizzard 5 parts, 20 parts, lotus seeds, Gorgon fruit 4 parts, Chinese yam 40 parts, the seed of Job's tears 60 parts, lily 30 parts, 20 parts, wheat bran, 10 parts, potash.
3. treat a preparation technology for the vermicelli of diabetes, it is characterized in that, comprise the steps:
(1) konjaku flour, gingko, hawthorn, the membrane of a chicken's gizzard, lotus seeds, Gorgon fruit, Chinese yam, the seed of Job's tears, lily are pressed formula co-grinding, through the processing of high speed pulverizing mill, fineness is 200-220 order;
(2) processed through high speed pulverizing mill by wheat bran, fineness is 200-220 order again;
(3) then highland barley flour, wheat flour and Gluten are pulverized processing, fineness is 80-100 order;
(4) above-mentioned raw materials is fully adjusted powder through powdered food product premixing mixing apparatus;
(5) by the semi-finished product obtained in step (4), liquid is made for subsequent use;
(6) major ingredient is mixed, be equipped with the auxiliary material got ready and become dough;
(7) dough is put into aging machine slaking;
(8) finally finished product vermicelli are made through compressing tablet, slitting and drying again.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610051132.6A CN105520054A (en) | 2016-01-21 | 2016-01-21 | Formula of fine dried noodles for treating diabetes and preparation process |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610051132.6A CN105520054A (en) | 2016-01-21 | 2016-01-21 | Formula of fine dried noodles for treating diabetes and preparation process |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105520054A true CN105520054A (en) | 2016-04-27 |
Family
ID=55762966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610051132.6A Withdrawn CN105520054A (en) | 2016-01-21 | 2016-01-21 | Formula of fine dried noodles for treating diabetes and preparation process |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105520054A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105942190A (en) * | 2016-05-20 | 2016-09-21 | 苏州穗儿食品科技有限公司 | Apple-flavored B-shaped pasta and production method thereof |
CN105942191A (en) * | 2016-05-20 | 2016-09-21 | 苏州穗儿食品科技有限公司 | Heart-shaped walnut noodles and production method thereof |
CN105995506A (en) * | 2016-05-20 | 2016-10-12 | 苏州穗儿食品科技有限公司 | Mange-flavor petal noodles and method for producing same |
CN105995504A (en) * | 2016-05-20 | 2016-10-12 | 苏州穗儿食品科技有限公司 | Whey-protein rabbit-head-shaped noodles and production method thereof |
CN107156643A (en) * | 2017-04-19 | 2017-09-15 | 任国亮 | Diabetes patient noodles |
CN107912698A (en) * | 2017-11-15 | 2018-04-17 | 南阳麦香源食品有限公司 | A kind of gordon euryale yam face and its preparation process |
-
2016
- 2016-01-21 CN CN201610051132.6A patent/CN105520054A/en not_active Withdrawn
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105942190A (en) * | 2016-05-20 | 2016-09-21 | 苏州穗儿食品科技有限公司 | Apple-flavored B-shaped pasta and production method thereof |
CN105942191A (en) * | 2016-05-20 | 2016-09-21 | 苏州穗儿食品科技有限公司 | Heart-shaped walnut noodles and production method thereof |
CN105995506A (en) * | 2016-05-20 | 2016-10-12 | 苏州穗儿食品科技有限公司 | Mange-flavor petal noodles and method for producing same |
CN105995504A (en) * | 2016-05-20 | 2016-10-12 | 苏州穗儿食品科技有限公司 | Whey-protein rabbit-head-shaped noodles and production method thereof |
CN107156643A (en) * | 2017-04-19 | 2017-09-15 | 任国亮 | Diabetes patient noodles |
CN107912698A (en) * | 2017-11-15 | 2018-04-17 | 南阳麦香源食品有限公司 | A kind of gordon euryale yam face and its preparation process |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105520054A (en) | Formula of fine dried noodles for treating diabetes and preparation process | |
CN104431770B (en) | High-fiber high-protein noodles for diabetes patient and overweight person | |
CN104187331A (en) | Special flour for diabetes nutrition recipe | |
CN101116503A (en) | Health products for reducing blood sugar and method for preparing the same | |
CN106360310A (en) | Composition for dropping after meal blood sugar and application thereof | |
CN104415061B (en) | Edible composition and its production and use | |
CN104171921B (en) | Special low albumen noodles of diabetic nephropathy patients undergoing and preparation method thereof | |
CN101112211B (en) | Antihyperglycemic milk and method for making the same | |
CN109010616A (en) | A kind of pure plant preparation for increasing beneficial bacteria of intestinal tract, improving intestinal flora | |
CN101695370B (en) | Health-care product for reducing blood sugar in assistant mode and preparation method thereof | |
CN101606978B (en) | Blood-sugar reducing tea and preparation method thereof | |
Lindström et al. | An oat bran-based beverage reduce postprandial glycaemia equivalent to yoghurt in healthy overweight subjects | |
CN107569482B (en) | Application of the artemisine compounds in preparation treatment embryonal-cell lipoma drug | |
CN102204650A (en) | Health staple food with low glycemic index, its preparation method and application in blood sugar reduction | |
CN105249441A (en) | Folium mori health care product for reducing blood glucose and preparation method thereof | |
CN101810649A (en) | Method for preparing pine needle distilled and concentrated solution | |
CN101524153A (en) | Health-care wheat flour beneficial for diabetes patients | |
CN107410642A (en) | It is a kind of to be used to improve kelp cordyceps sinensis pressed candy of male's renal function and preparation method thereof | |
CN1286503C (en) | A Chinese medicinal composition with blood sugar and blood lipid reducing effects, and its preparation method | |
CN109700024A (en) | Balsam pear peptide combinations | |
TWI676473B (en) | Uses of poria cocos epidermis extract, poricoic acid a, and poricoic acid b in regulating blood glucose level | |
CN101716229A (en) | Health-care tea for regulating blood sugar level and preparation method thereof | |
CN101352498B (en) | Formulation for improving thirst, polyphagia, hypodynamia and polyuria of diabetes patients | |
CN110302213A (en) | Maggot is for treating the application in diabetes | |
CN108142784A (en) | A kind of wheat composite flour and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160427 |
|
WW01 | Invention patent application withdrawn after publication |